C-HBP

T:HBP - HELIX BIOPHARMA CORP. - https://www.helixbiopharma.com

04:23:10 EDT

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
HBP - T	0.3	0.95	·	1.45	6.1	1.435	+0.045	3.2	0.4	0	14	1.42 1.435 1.42	5.40 0.95	14:39:25	Jun 30	15 min RT 2¢
TSX - T	0.3	0.95	·	1.45	6.1	1.435	+0.045	3.2	0.2	0	3	1.42 1.435 1.42	5.40 0.95	14:39:25		15 min
CSE ATS - P						1.39			0.01		1					15 min
CXD - D						1.435	+0.045	3.2	0.2	0	6	1.435 1.435 1.435		14:37:37		15 min
MatchNOW - M						1.39			0.01		4			Sep 01/20		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 14

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:54:25	M	1.45	0.06	5	7 TD Sec	80 National Bank	E
15:48:24	P	1.42	0.03	13	7 TD Sec	1 Anonymous	E
15:30:23	M	1.45	0.06	1	7 TD Sec	2 RBC	E
14:56:58	M	1.45	0.06	1	7 TD Sec	2 RBC	E
14:39:45	M	1.42	0.03	4	2 RBC	7 TD Sec	E
14:39:25	T	1.435	0.045	100	1 Anonymous	79 CIBC	K
14:37:37	D	1.435	0.045	100	1 Anonymous	79 CIBC	K
14:35:20	T	1.42	0.03	100	1 Anonymous	1 Anonymous	KL
14:17:26	D	1.36	-0.03	1	80 National Bank	80 National Bank	E
11:26:36	D	1.42	0.03	28	80 National Bank	80 National Bank	E

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Date ET	Symbol	Price	Type	Headline
2026-06-30 17:15	C:HBP	1.45	News Release200	Helix BioPharma Corp. Strengthens Executive Leadership to Support U.S. Listing Strategy and Next Phase of Clinical Development
2026-06-12 18:15	C:HBP	1.58	News Release200	Helix Biopharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Nine-Month Periods Ended April 30, 2026
2026-06-12 17:08	C:HBP	1.58	SEDAR Interim MD & A813	SEDAR Interim MD & A
2026-06-12 17:05	C:HBP	1.58	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2026-06-03 17:15	C:HBP	1.58	News Release200	Helix BioPharma Corp. Announces Closing of Private Placement of Convertible Debentures
2026-05-22 17:32	C:HBP	1.63	News Release200	Helix BioPharma grants options to buy 1.29M shares
2026-05-13 16:15	C:HBP	1.60	News Release200	Helix Biopharma Corp. Announces Strategic Board and Governance Appointments to Support Financing and Nasdaq Uplisting Strategy
2026-03-16 17:42	C:HBP		SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2026-03-16 17:00	C:HBP	1.79	News Release200	Helix BioPharma Corp. Announces Financial Results and Filing of Interim Financial Statements as of and for the Three- and Six-Month Periods Ended January 31, 2026
2026-03-16 16:23	C:HBP		SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2026-03-16 16:23	C:HBP		SEDAR Interim MD & A813	SEDAR Interim MD & A
2026-02-24 09:00	C:HBP	2.00	News Release200	Helix BioPharma Corp. Announces Presentation at 16th Annual World ADC London
2026-02-05 16:30	C:HBP	1.83	News Release200	Helix Biopharma Corp. Extends LEUMUNA Option with metaShape Pharma for Adipose Tissue-Related and Metabolic Diseases
2026-01-30 18:03	C:HBP	2.03	News Release200	Helix BioPharma holders OK all business items at AGM
2025-12-15 17:30	C:HBP	2.05	News Release200	Helix BioPharma Corp. Announces Filing of Interim Financial Statements as of and for the Three-Month Period Ended October 31, 2025
2025-12-12 16:25	C:HBP	2.04	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-12-12 16:25	C:HBP	2.04	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-10-29 17:59	C:HBP		SEDAR MD & A815	SEDAR MD & A
2025-10-29 13:52	C:HBP	2.09	SEDAR Annual Information Form802	SEDAR Annual Information Form
2025-10-29 12:45	C:HBP	2.09	News Release200	Helix BioPharma Corp. Announces Fiscal 2025 Year-End Results

Date ET

Symbol

Price

Type

Headline

2026-06-30 17:15

C:HBP

1.45

News Release

Helix BioPharma Corp. Strengthens Executive Leadership to Support U.S. Listing Strategy and Next Phase of Clinical Development

2026-06-12 18:15

C:HBP